Document Classification

Section Type: METHODS

Text: A total of 210 patients were randomly assigned to one of three treatment arms : gemcitabine 1, 250 mg/m (2) Days 1 and 8 and paclitaxel 175 mg/m (2) as a 3-h infusion on Day 1 (GP1) ; gemcitabine 1, 000 mg/m (2) Days 1 and 8 and paclitaxel 100 mg/m (2) as a 1-h infusion on Days 1 and 8 (GP2) ; gemcitabine 1, 000 mg/m (2) Days 1 and 8 and docetaxel 40 mg/m (2) as a 1-h infusion on Days 1 and 8 (GD).